ARS-853 is a Selective KRAS (G12C) Inhibitor
KRAS mutations have wide-spread prevalence in human cancers nowadays. KRASG12C mutations occur in 16% of lung adenocarcinomas, making them one of the most frequent activating genetic alterations in lung cancer. The mis-sense…